EX-10.26 26 dex1026.htm OPTION AND LICENSE AGREEMENT, BIOGEN IDEC INTERNATIONAL GMBH Execution Copy Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. OPTION AND LICENSE...Option and License Agreement • May 5th, 2020 • Massachusetts
Contract Type FiledMay 5th, 2020 JurisdictionThis Option and License Agreement, made this 18th day of March, 2009 (the “Effective Date”), is by and between AVEO Pharmaceuticals, Inc., a Delaware corporation, with principal offices located at 75 Sidney St., Cambridge, MA 02139 (“AVEO”) and Biogen Idec International GmbH, with principal offices located at Landis+Gyr-Strasse 3, 6300 Zug, Switzerland (“Biogen Idec”). Each of AVEO and Biogen Idec shall be referred to, individually, as a “Party”, and, collectively, as the “Parties”.
OPTION AND LICENSE AGREEMENTOption and License Agreement • May 9th, 2012 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 9th, 2012 Company Industry Jurisdiction
OPTION AND LICENSE AGREEMENTOption and License Agreement • December 16th, 2009 • Aveo Pharmaceuticals Inc • Massachusetts
Contract Type FiledDecember 16th, 2009 Company Jurisdiction